Riskpilot← Back to searchSign inGet full accessC-OPTIKK NITTEDAL AS
ASActiveOrg 991022228Ånebyveien 9, 1484 HakadalRetail sale of medical and orthopaedic goods · NACE 4774Est. 20073 employees
Revenue 2024
NOK 4,4M
-13% vs 2023
EBITDA margin
2.3%
+127% vs 2023
Equity ratio
39.5%
Financial strength
Net profit 2024
NOK -76K
+84% vs 2023
| Revenue | NOK 4,4M | -13% |
| EBITDA | NOK 103K | +127% |
| Net profit | NOK -76K | +84% |
| Total assets | NOK 2,6M | +9% |
| Equity | NOK 1M | -7% |
| Employees | 3 | — |
Legal name
C-OPTIKK NITTEDAL AS
Org number
991022228
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
20. mars 2007
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kjøp, salg og service på optikk og ur, samt hva derved står i forbindelse.
Address
Ånebyveien 9, 1484 Hakadal
Phone
+4748990892
Email
epost@nittedaloptiske.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 184 | 5 908 | 6 192 | 5 068 | 4 424 |
| Staff expenses | −1 680 | −2 062 | −2 264 | −2 855 | −2 296 |
| EBITDA | 798 | 1 034 | 842 | −377 | 103 |
| Depreciation & amort. | −231 | −198 | −131 | −104 | −134 |
| EBIT | 567 | 836 | 711 | −481 | −31 |
| Net financials | −21 | 3 | 13 | −6 | −45 |
| Profit before tax | 546 | 839 | 723 | −488 | −76 |
| Tax | 115 | 175 | 138 | −15 | −0 |
| Net profit | 431 | 663 | 585 | −473 | −76 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 846 | 4 412 | 4 336 | 2 381 | 2 594 |
| Equity | 2 811 | 2 974 | 1 572 | 1 099 | 1 024 |
| Long-term debt | 209 | 92 | 15 | 773 | 973 |
| Short-term debt | 826 | 1 346 | 2 749 | 509 | 598 |
| Total debt | 1 035 | 1 437 | 2 764 | 1 282 | 1 570 |
EBITDA margin
2.3%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
39.5%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
-7.4%
This company
18.4%
Market median
-140% vs market
20202024
Net profit margin
-1.7%
This company
8.1%
Market median
-121% vs market
20202024
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
20202024
Debt / equity
1.53×
This company
0.62×
Market median
-147% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SS Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
PN Deputy Member | Deputy Member | 2007 – 2021 |
KN Deputy Member | Deputy Member | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Chairman | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sindre Svendby As
C-OPTIKK NITTEDAL AS Board members of C-OPTIKK NITTEDAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Norbeck | Deputy Member | 0 companies |
| Kaja Norbeck | Deputy Member | 0 companies |
| Sindre Svendby | Chief Executive Officer | 0 companies |
| Erlend Svendby | Board of Directors | 0 companies |
| Anne Norbeck | Chairman | 0 companies |
| Vidar Svendby | Board of Directors | 0 companies |